GlaxoSmithKline

NCT07502560

Phase 4Recruiting33,609 people31 Mar 2026clinicaltrials.gov

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

Phase 3Recruiting600 people16 Dec 2025clinicaltrials.gov

NCT07285239

CollaboratorPhase 3Recruiting500 people16 Dec 2025clinicaltrials.gov

NCT07227311

Phase 2Recruiting200 people12 Nov 2025clinicaltrials.gov

NCT07224672

Phase 2Recruiting60 people5 Nov 2025clinicaltrials.gov

NCT07150104

Phase 1/2Active, not recruiting14 people2 Sept 2025clinicaltrials.gov

NCT07150091

Phase 1/2Active, not recruiting20 people2 Sept 2025clinicaltrials.gov

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Phase 3Recruiting961 people7 May 2025clinicaltrials.gov

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Phase 3Recruiting981 people6 May 2025clinicaltrials.gov

NCT06956170

Phase 3Active, not recruiting21 people4 May 2025clinicaltrials.gov

NCT06868667

Phase 3Active, not recruiting24 people11 Mar 2025clinicaltrials.gov

NCT06868654

Phase 3Active, not recruiting72 people11 Mar 2025clinicaltrials.gov

NCT06679101

Phase 3Recruiting520 people7 Nov 2024clinicaltrials.gov

NCT06551142

Phase 1Recruiting845 people13 Aug 2024clinicaltrials.gov

NCT06023862

CollaboratorPhase 2Recruiting198 people5 Sept 2023clinicaltrials.gov

NCT05922501

CollaboratorPhase 2Recruiting50 people28 Jun 2023clinicaltrials.gov

NCT05789303

CollaboratorPhase 2Recruiting83 people29 Mar 2023clinicaltrials.gov

Shingrix In Recipients of Allogeneic Transplants

CollaboratorPhase 2Recruiting55 people20 Mar 2023clinicaltrials.gov

NCT05714839

Phase 1/2Recruiting123 people6 Feb 2023clinicaltrials.gov

NCT05659381

CollaboratorPhase 3Recruiting220 people21 Dec 2022clinicaltrials.gov